Dmytro Khadzhynov1, Danilo Schmidt, Juliane Hardt, Geraldine Rauch, Peter Gocke, Kai-Uwe Eckardt, Kai M Schmidt-Ott. 1. Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin and Berlin Institute of Health, Berlin; Business Division IT, Department of Research and Teaching, Charité-Universitätsmedizin Berlin, Berlin; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin and Berlin Institute of Health, Berlin; Biostatistics, Clinical Research Unit, Berlin Institute of Health, Berlin; Administrative Office for Digital Transformation, Charité - -Universitätsmedizin Berlin, Berlin.
Abstract
BACKGROUND: Studies from multiple countries have shown that acute kidney injury (AKI) in hospitalized patients is associated with mortality and morbidity. There are no reliable data at present on the incidence and mortality of AKI episodes among hospitalized patients in Germany. The utility of administrative codings of AKI for the identification of AKI episodes is also unclear. METHODS: In an exploratory approach, we retrospectively analyzed all episodes of AKI over a period of 3.5 years (2014-2017) on the basis of routinely obtained serum creatinine measurements in 103 161 patients whose creatinine had been measured at least twice and who had been in the hospital for at least two days. We used the "Kidney Disease: Improving Global Outcomes" (KDIGO) criteria for AKI. In parallel, we assessed the administrative coding of discharge diagnoses of the same patients with codes from the International Classification of Diseases (ICD-10-GM). RESULTS: Among 185 760 hospitalizations, stage 1 AKI occurred in 25 417 cases (13.7%), stage 2 in 8503 cases (4.6%), and stage 3 in 5881 cases (3.1%). AKI cases were associated with length of hospital stay, renal morbidity, and overall mortality, and this association was stage-dependent. The in-hospital mortality was 5.1% for patients with stage 1 AKI, 13.7% for patients with stage 2 AKI, and 24.8% for patients with stage 3 AKI. An administrative coding for acute kidney injury (N17) was present in only 28.8% (11 481) of the AKI cases that were identified by creatinine criteria. Like the AKI cases overall, those that were identified by creatinine criteria but were not coded as AKI had significantly higher mortality, and this association was stage-dependent. CONCLUSION: AKI episodes are common among hospitalized patients and are associated with considerable morbidity and mortality, yet they are inadequately documented and probably often escape the attention of the treating physicians.
BACKGROUND: Studies from multiple countries have shown that acute kidney injury (AKI) in hospitalized patients is associated with mortality and morbidity. There are no reliable data at present on the incidence and mortality of AKI episodes among hospitalized patients in Germany. The utility of administrative codings of AKI for the identification of AKI episodes is also unclear. METHODS: In an exploratory approach, we retrospectively analyzed all episodes of AKI over a period of 3.5 years (2014-2017) on the basis of routinely obtained serum creatinine measurements in 103 161 patients whose creatinine had been measured at least twice and who had been in the hospital for at least two days. We used the "Kidney Disease: Improving Global Outcomes" (KDIGO) criteria for AKI. In parallel, we assessed the administrative coding of discharge diagnoses of the same patients with codes from the International Classification of Diseases (ICD-10-GM). RESULTS: Among 185 760 hospitalizations, stage 1 AKI occurred in 25 417 cases (13.7%), stage 2 in 8503 cases (4.6%), and stage 3 in 5881 cases (3.1%). AKI cases were associated with length of hospital stay, renal morbidity, and overall mortality, and this association was stage-dependent. The in-hospital mortality was 5.1% for patients with stage 1 AKI, 13.7% for patients with stage 2 AKI, and 24.8% for patients with stage 3 AKI. An administrative coding for acute kidney injury (N17) was present in only 28.8% (11 481) of the AKI cases that were identified by creatinine criteria. Like the AKI cases overall, those that were identified by creatinine criteria but were not coded as AKI had significantly higher mortality, and this association was stage-dependent. CONCLUSION: AKI episodes are common among hospitalized patients and are associated with considerable morbidity and mortality, yet they are inadequately documented and probably often escape the attention of the treating physicians.
Authors: Jose Calvo Broce; Lori Lyn Price; Orfeas Liangos; Katrin Uhlig; Bertrand L Jaber Journal: Clin J Am Soc Nephrol Date: 2011-06-23 Impact factor: 8.237
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: G M Chertow; S H Soroko; E P Paganini; K C Cho; J Himmelfarb; T A Ikizler; R L Mehta Journal: Kidney Int Date: 2006-07-19 Impact factor: 10.612
Authors: Azra Bihorac; Sinan Yavas; Sophie Subbiah; Charles E Hobson; Jesse D Schold; Andrea Gabrielli; A Joseph Layon; Mark S Segal Journal: Ann Surg Date: 2009-05 Impact factor: 12.969
Authors: Jay L Xue; Frank Daniels; Robert A Star; Paul L Kimmel; Paul W Eggers; Bruce A Molitoris; Jonathan Himmelfarb; Allan J Collins Journal: J Am Soc Nephrol Date: 2006-02-22 Impact factor: 10.121
Authors: Orfeas Liangos; Ron Wald; John W O'Bell; Lorilyn Price; Brian J Pereira; Bertrand L Jaber Journal: Clin J Am Soc Nephrol Date: 2005-10-26 Impact factor: 8.237
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Anja Haase-Fielitz; Saban Elitok; Martin Schostak; Martin Ernst; Berend Isermann; Christian Albert; Bernt-Peter Robra; Andreas Kribben; Michael Haase Journal: Dtsch Arztebl Int Date: 2020-04-24 Impact factor: 5.594
Authors: Jan-Hendrik B Hardenberg; Helena Stockmann; Annette Aigner; Inka Gotthardt; Philipp Enghard; Christian Hinze; Felix Balzer; Danilo Schmidt; Daniel Zickler; Jan Kruse; Roland Körner; Miriam Stegemann; Thomas Schneider; Michael Schumann; Holger Müller-Redetzky; Stefan Angermair; Klemens Budde; Steffen Weber-Carstens; Martin Witzenrath; Sascha Treskatsch; Britta Siegmund; Claudia Spies; Norbert Suttorp; Geraldine Rauch; Kai-Uwe Eckardt; Kai M Schmidt-Ott Journal: Kidney Int Rep Date: 2021-02-02
Authors: Kirby P Mayer; Victor M Ortiz-Soriano; Alborz Kalantar; Joshua Lambert; Peter E Morris; Javier A Neyra Journal: BMC Nephrol Date: 2022-04-07 Impact factor: 2.388
Authors: Ralph Weber; Robert van Hal; Paul Stracke; Jeffrie Hadisurya; Hannes Nordmeyer; René Chapot Journal: J Am Heart Assoc Date: 2020-02-13 Impact factor: 5.501